CIK 0000818033
- Accelerated filer
HERON THERAPEUTICS, INC. /DE/
Sign in to watch- Ticker
- HRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 942875566
- Phone
- +1 858-251-4400
- Business address
- 4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
- 4 Exercise or conversion Chief Executive Officer acquired 14,306 shares (option exercise)
- 4 Exercise or conversion Chief Executive Officer acquired 10,000 shares (option exercise)
- 4 Open-market buy Director bought 121,212 shares at $24.75 ($2,999,997)
- 4 Open-market sale Director sold 13,208 shares at an average $23.09 ($304,918)
- 4 Open-market buy Director bought 150,000 shares at an average $20.62 ($3,092,285)
- 4 Open-market sale SVP, Technical Operations sold 70,000 shares at an average $14.69 ($1,028,000)
- 4 Open-market sale Chief Executive Officer sold 10,000 shares at $13.07 ($130,727)
- 5 Insider Annual Insider Trading Report
- 5 Insider Annual Insider Trading Report
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Chief Executive Officer acquired 1,941 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition VP, Finance & CFO acquired 818 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 120,313 shares (option exercise)
Page 17 of 30 · 585 filings